The Ensign Group (NASDAQ:ENSG) Releases Earnings Results, Beats Estimates By $0.06 EPS

Posted by Stanley Muller on May 2nd, 2026

The Ensign Group (NASDAQ:ENSG – Get Free Report) announced its earnings results on Thursday. The company reported $1.85 EPS for the quarter, beating analysts’ consensus estimates of $1.79 by $0.06, FiscalAI reports. The business had revenue of $1.39 billion for the quarter, compared to analysts’ expectations of $1.40 billion. The Ensign Group had a net margin of 6.89% and a return on equity of 17.26%. The company’s quarterly revenue was up 18.4% on a year-over-year basis. During the same period in the previous year, the company posted $1.52 EPS. The Ensign Group updated its FY 2026 guidance to 7.480-7.620 EPS.

The Ensign Group Stock Performance

ENSG traded down $2.97 during trading on Friday, hitting $183.72. The stock had a trading volume of 838,126 shares, compared to its average volume of 337,796. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.42 and a current ratio of 1.42. The firm has a market capitalization of $10.64 billion, a P/E ratio of 31.46, a PEG ratio of 1.83 and a beta of 0.73. The company’s 50-day moving average price is $202.39 and its 200 day moving average price is $189.26. The Ensign Group has a twelve month low of $128.08 and a twelve month high of $218.00.

The Ensign Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, April 30th. Shareholders of record on Tuesday, March 31st were paid a $0.065 dividend. This represents a $0.26 annualized dividend and a yield of 0.1%. The ex-dividend date of this dividend was Tuesday, March 31st. The Ensign Group’s payout ratio is currently 4.45%.

Insider Buying and Selling

In other news, VP Beverly B. Wittekind sold 500 shares of the company’s stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $210.23, for a total transaction of $105,115.00. Following the transaction, the vice president directly owned 32,779 shares of the company’s stock, valued at $6,891,129.17. This represents a 1.50% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Daren Shaw sold 1,000 shares of the company’s stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $213.43, for a total transaction of $213,430.00. Following the transaction, the director directly owned 23,726 shares in the company, valued at approximately $5,063,840.18. This trade represents a 4.04% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 17,173 shares of company stock worth $3,377,311 in the last ninety days. Insiders own 4.00% of the company’s stock.

Institutional Investors Weigh In On The Ensign Group

Institutional investors and hedge funds have recently made changes to their positions in the business. Northwestern Mutual Wealth Management Co. boosted its position in shares of The Ensign Group by 55.0% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 172 shares of the company’s stock worth $30,000 after buying an additional 61 shares in the last quarter. Larson Financial Group LLC boosted its position in shares of The Ensign Group by 76.9% in the 3rd quarter. Larson Financial Group LLC now owns 207 shares of the company’s stock worth $36,000 after buying an additional 90 shares in the last quarter. Wexford Capital LP purchased a new stake in shares of The Ensign Group in the 3rd quarter worth about $41,000. Geneos Wealth Management Inc. boosted its position in shares of The Ensign Group by 150.3% in the 1st quarter. Geneos Wealth Management Inc. now owns 383 shares of the company’s stock worth $50,000 after buying an additional 230 shares in the last quarter. Finally, Measured Wealth Private Client Group LLC purchased a new stake in shares of The Ensign Group in the 3rd quarter worth about $53,000. 96.12% of the stock is currently owned by hedge funds and other institutional investors.

Key Headlines Impacting The Ensign Group

Here are the key news stories impacting The Ensign Group this week:

Positive Sentiment: Q1 EPS beat — Ensign reported earnings of $1.85 per share versus the Zacks consensus of $1.79, up from $1.52 a year ago (accelerating profitability). Article Title
Positive Sentiment: Raised FY‑2026 guidance — management lifted full‑year EPS guidance to roughly 7.48–7.62 (above consensus) and raised revenue targets, signaling confidence in growth and margins. Article Title
Positive Sentiment: Portfolio expansion — Ensign announced acquisitions and real‑estate purchases (Texas and Wisconsin), expanding operating footprint and REIT-owned assets that should support revenue/lease income. Article Title
Neutral Sentiment: Conference call/webcast scheduled — management will host a call and provide slides tomorrow; useful for color on patient mix, margin drivers and the assumptions behind the raised guidance. Article Title
Negative Sentiment: Revenue slightly missed estimates — Q1 revenue came in about $1.39B vs. ~$1.40B consensus; some coverage flagged sales below estimates, which can temper enthusiasm despite the EPS beat. Article Title

Wall Street Analysts Forecast Growth

ENSG has been the topic of a number of recent research reports. Truist Financial set a $215.00 target price on shares of The Ensign Group and gave the company a “hold” rating in a report on Friday, February 6th. UBS Group set a $230.00 target price on shares of The Ensign Group and gave the company a “buy” rating in a report on Friday, February 6th. Wall Street Zen raised shares of The Ensign Group from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Royal Bank Of Canada reissued an “outperform” rating and issued a $222.00 price objective (up from $206.00) on shares of The Ensign Group in a research note on Monday, February 9th. Finally, Zacks Research cut shares of The Ensign Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 6th. Four analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $216.75.

Check Out Our Latest Stock Report on The Ensign Group

The Ensign Group Company Profile

(Get Free Report)

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.